[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:intravascular-large-b-cell-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Intravascular Large B-Cell Lymphoma",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06834373","Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy",[11],"Phase 2","RECRUITING","2026-08-26T02:16:14.341106Z","2026-05-05T02:43:26.687370Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06736613","A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma",[11],"2026-08-26T02:19:01.741747Z","2026-05-05T02:43:29.366355Z",[],[]]